Rexcel Pharmaceuticals Limited - Company Profile

It is a chemicals public limited company based in New Delhi, Delhi, India, established in 1997.
1997 New Delhi, Delhi, India Amalgamated
Last Updated:
Access Report
About Rexcel Pharmaceuticals Limited

Rexcel Pharmaceuticals Limited, a amalgamated public limited company, was established on 03 March 1997 in New Delhi, Delhi, India. Engaging in pharmaceutical chemical within the chemicals sector, it holds CIN: U24231DL1997PLC085491. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹12.50 Cr.

Its leadership includes Sanjeev Indravadan Dani (Director), Ashwani Kumar Malhotra (Nominee Director), Ranjit Kohli (Director). Past directors included Ashwani Kumar Malhotra, Ramesh Kumar Parekh, Ranjit Kohli. Its latest AGM occurred on 10 May 2012, with the balance sheet filed on 31 December 2011. It is based at 12Th Floor, Devika Tower, Nehru Place, New Delhi, Delhi, 110019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231DL1997PLC085491

  • Registration Number

    085491

  • Incorporation Date

    03 March 1997

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹12.50 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 12.50 Cr
  • Company Age 28 Year, 11 Months
  • Last Filing with ROC 31 Dec 2011
Company report

Rexcel Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rexcel Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rexcel Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Sanjeev Indravadan Dani Director 28 Jul 2005 Current
Ashwani Kumar Malhotra Nominee Director 01 Nov 2010 Current
Ranjit Kohli Director 12 Mar 2012 Current
Sandeep Mehandroo Director 30 Jan 2008 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 10 May 2011 Past
Pramod Abcsdd Director 18 Oct 2010 Past
Pramod Abcsdd Additional Director 10 May 2012 Past
Pramod Abcsdd Director Appointed In Casual Vacancy 28 May 2009 Past
Pramod Abcsdd Director 18 Oct 2010 Past
Pramod Abcsdd Nominee Director 12 Mar 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rexcel Pharmaceuticals.

Enhance accessibility to Rexcel Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Rexcel Pharmaceuticals revenue growth over time
Rexcel Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rexcel Pharmaceuticals?

Unlock access to Rexcel Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rexcel Pharmaceuticals?

Unlock and access historical data on people associated with Rexcel Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rexcel Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rexcel Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rexcel Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Rexcel Pharmaceuticals Limited last Annual general meeting of members was held on 10 May 2012 as per latest MCA records. was documented.

  • Director Appointment

    The activity Ranjit Kohli was appointed as a Director was appointed as a Director on 12 Mar 2012 & has been associated with this company since 13 years 11 months . was completed.

  • Balance Sheet

    The activity Rexcel Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Dec 2011 with Roc Delhi. was completed.

  • Director Appointment

    The activity Ashwani Kumar Malhotra was appointed as a Nominee Director was appointed as a Nominee Director on 01 Nov 2010 & has been associated with this company since 15 years 3 months . was completed.

  • Director Appointment

    The activity Sandeep Mehandroo was appointed as a Director was appointed as a Director on 30 Jan 2008 & has been associated with this company since 18 years 30 days . was completed.

  • Director Appointment

    Sanjeev Indravadan Dani was appointed as a Director was appointed as a Director on 28 Jul 2005 & has been associated with this company since 20 years 7 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rexcel Pharmaceuticals Limited?

The CIN of Rexcel Pharmaceuticals Limited is U24231DL1997PLC085491.

Where is Rexcel Pharmaceuticals Limited headquartered?

Rexcel Pharmaceuticals Limited is headquartered at 12Th Floor, Devika Tower, Nehru Place, New Delhi, Delhi, 110019.

When was Rexcel Pharmaceuticals Limited incorporated?

Rexcel Pharmaceuticals Limited was incorporated on 03 March 1997.

Who are the current directors of Rexcel Pharmaceuticals Limited?

The current directors of Rexcel Pharmaceuticals Limited are

What is the primary industry of Rexcel Pharmaceuticals Limited?

The primary industry of Rexcel Pharmaceuticals Limited is Chemicals.

Is Rexcel Pharmaceuticals Limited a listed company?

Rexcel Pharmaceuticals Limited is unlisted.

What is the capital structure of Rexcel Pharmaceuticals Limited?

The authorized capital of Rexcel Pharmaceuticals Limited is ₹15.00 Cr, and the paid-up capital is ₹12.50 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available